Rheumatic Disorders Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Rheumatic Disorders Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rheumatic Disorders Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rheumatic Disorders Drug Overall Market Size
2.1 Global Rheumatic Disorders Drug Market Size: 2022 VS 2030
2.2 Global Rheumatic Disorders Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rheumatic Disorders Drug Players in Global Market
3.2 Top Global Rheumatic Disorders Drug Companies Ranked by Revenue
3.3 Global Rheumatic Disorders Drug Revenue by Companies
3.4 Top 3 and Top 5 Rheumatic Disorders Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Rheumatic Disorders Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rheumatic Disorders Drug Players in Global Market
3.6.1 List of Global Tier 1 Rheumatic Disorders Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Rheumatic Disorders Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Rheumatic Disorders Drug Market Size Markets, 2022 & 2030
4.1.2 Acting on Tumor Necrosis Factor-Alpha
4.1.3 Acting on Interleukins and Interleukin Receptors
4.1.4 Acting on Protein Kinases
4.1.5 Acting on Cell Surface Antigens
4.1.6 Acting on Hormones and Hormone Receptors
4.1.7 Others
4.2 By Type - Global Rheumatic Disorders Drug Revenue & Forecasts
4.2.1 By Type - Global Rheumatic Disorders Drug Revenue, 2018-2023
4.2.2 By Type - Global Rheumatic Disorders Drug Revenue, 2024-2030
4.2.3 By Type - Global Rheumatic Disorders Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rheumatic Disorders Drug Market Size, 2022 & 2030
5.1.2 Rheumatoid Arthritis
5.1.3 Osteoarthritis
5.1.4 Osteoporosis
5.1.5 Systemic Lupus Erythematosus
5.1.6 Psoriatic Arthritis
5.1.7 Others
5.2 By Application - Global Rheumatic Disorders Drug Revenue & Forecasts
5.2.1 By Application - Global Rheumatic Disorders Drug Revenue, 2018-2023
5.2.2 By Application - Global Rheumatic Disorders Drug Revenue, 2024-2030
5.2.3 By Application - Global Rheumatic Disorders Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Rheumatic Disorders Drug Market Size, 2022 & 2030
6.2 By Region - Global Rheumatic Disorders Drug Revenue & Forecasts
6.2.1 By Region - Global Rheumatic Disorders Drug Revenue, 2018-2023
6.2.2 By Region - Global Rheumatic Disorders Drug Revenue, 2024-2030
6.2.3 By Region - Global Rheumatic Disorders Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Rheumatic Disorders Drug Revenue, 2018-2030
6.3.2 US Rheumatic Disorders Drug Market Size, 2018-2030
6.3.3 Canada Rheumatic Disorders Drug Market Size, 2018-2030
6.3.4 Mexico Rheumatic Disorders Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Rheumatic Disorders Drug Revenue, 2018-2030
6.4.2 Germany Rheumatic Disorders Drug Market Size, 2018-2030
6.4.3 France Rheumatic Disorders Drug Market Size, 2018-2030
6.4.4 U.K. Rheumatic Disorders Drug Market Size, 2018-2030
6.4.5 Italy Rheumatic Disorders Drug Market Size, 2018-2030
6.4.6 Russia Rheumatic Disorders Drug Market Size, 2018-2030
6.4.7 Nordic Countries Rheumatic Disorders Drug Market Size, 2018-2030
6.4.8 Benelux Rheumatic Disorders Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Rheumatic Disorders Drug Revenue, 2018-2030
6.5.2 China Rheumatic Disorders Drug Market Size, 2018-2030
6.5.3 Japan Rheumatic Disorders Drug Market Size, 2018-2030
6.5.4 South Korea Rheumatic Disorders Drug Market Size, 2018-2030
6.5.5 Southeast Asia Rheumatic Disorders Drug Market Size, 2018-2030
6.5.6 India Rheumatic Disorders Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Rheumatic Disorders Drug Revenue, 2018-2030
6.6.2 Brazil Rheumatic Disorders Drug Market Size, 2018-2030
6.6.3 Argentina Rheumatic Disorders Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rheumatic Disorders Drug Revenue, 2018-2030
6.7.2 Turkey Rheumatic Disorders Drug Market Size, 2018-2030
6.7.3 Israel Rheumatic Disorders Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Rheumatic Disorders Drug Market Size, 2018-2030
6.7.5 UAE Rheumatic Disorders Drug Market Size, 2018-2030
7 Rheumatic Disorders Drug Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Rheumatic Disorders Drug Major Product Offerings
7.1.4 AbbVie Rheumatic Disorders Drug Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Rheumatic Disorders Drug Major Product Offerings
7.2.4 Amgen Rheumatic Disorders Drug Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Rheumatic Disorders Drug Major Product Offerings
7.3.4 Johnson & Johnson Rheumatic Disorders Drug Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Rheumatic Disorders Drug Major Product Offerings
7.4.4 Novartis Rheumatic Disorders Drug Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Rheumatic Disorders Drug Major Product Offerings
7.5.4 Pfizer Rheumatic Disorders Drug Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Rheumatic Disorders Drug Major Product Offerings
7.6.4 Roche Rheumatic Disorders Drug Revenue in Global Market (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Company Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Rheumatic Disorders Drug Major Product Offerings
7.7.4 Eli Lilly Rheumatic Disorders Drug Revenue in Global Market (2018-2023)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Rheumatic Disorders Drug Major Product Offerings
7.8.4 Bristol-Myers Squibb Rheumatic Disorders Drug Revenue in Global Market (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Rheumatic Disorders Drug Market Opportunities & Trends in Global Market
Table 2. Rheumatic Disorders Drug Market Drivers in Global Market
Table 3. Rheumatic Disorders Drug Market Restraints in Global Market
Table 4. Key Players of Rheumatic Disorders Drug in Global Market
Table 5. Top Rheumatic Disorders Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Rheumatic Disorders Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Rheumatic Disorders Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Rheumatic Disorders Drug Product Type
Table 9. List of Global Tier 1 Rheumatic Disorders Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatic Disorders Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Rheumatic Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Rheumatic Disorders Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Rheumatic Disorders Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Rheumatic Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Rheumatic Disorders Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Rheumatic Disorders Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Rheumatic Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Rheumatic Disorders Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Rheumatic Disorders Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Rheumatic Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Rheumatic Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Rheumatic Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Rheumatic Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Rheumatic Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 30. AbbVie Company Summary
Table 31. AbbVie Rheumatic Disorders Drug Product Offerings
Table 32. AbbVie Rheumatic Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Rheumatic Disorders Drug Product Offerings
Table 36. Amgen Rheumatic Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Rheumatic Disorders Drug Product Offerings
Table 40. Johnson & Johnson Rheumatic Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Rheumatic Disorders Drug Product Offerings
Table 44. Novartis Rheumatic Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Rheumatic Disorders Drug Product Offerings
Table 48. Pfizer Rheumatic Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Rheumatic Disorders Drug Product Offerings
Table 52. Roche Rheumatic Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Eli Lilly Company Summary
Table 55. Eli Lilly Rheumatic Disorders Drug Product Offerings
Table 56. Eli Lilly Rheumatic Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Eli Lilly Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Summary
Table 59. Bristol-Myers Squibb Rheumatic Disorders Drug Product Offerings
Table 60. Bristol-Myers Squibb Rheumatic Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol-Myers Squibb Key News & Latest Developments
List of Figures
Figure 1. Rheumatic Disorders Drug Segment by Type in 2022
Figure 2. Rheumatic Disorders Drug Segment by Application in 2022
Figure 3. Global Rheumatic Disorders Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rheumatic Disorders Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Rheumatic Disorders Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rheumatic Disorders Drug Revenue in 2022
Figure 8. By Type - Global Rheumatic Disorders Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Rheumatic Disorders Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Rheumatic Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Rheumatic Disorders Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Rheumatic Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Rheumatic Disorders Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Rheumatic Disorders Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Rheumatic Disorders Drug Revenue Market Share, 2018-2030
Figure 16. US Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Rheumatic Disorders Drug Revenue Market Share, 2018-2030
Figure 20. Germany Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Rheumatic Disorders Drug Revenue Market Share, 2018-2030
Figure 28. China Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Rheumatic Disorders Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Rheumatic Disorders Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Rheumatic Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 41. AbbVie Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Roche Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Eli Lilly Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol-Myers Squibb Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
